Bloomberg Law
Jan. 11, 2021, 5:12 PMUpdated: Jan. 11, 2021, 8:27 PM

FDA Chief Counsel Steps Down, Deputy to Become Acting Head (2)

Jeannie Baumann
Jeannie Baumann

The FDA’s top attorney, Stacy Cline Amin, will step down effective Monday, the agency’s head announced.

Cline Amin has served as chief counsel for the Food and Drug Administration since September 2018, coming to the agency after a year as senior associate counsel in the White House and after counsel positions in both the House and Senate committees with jurisdiction over the FDA’s work. Mark Raza, who has been the principal deputy chief counsel since 2011, will take over as acting chief counsel.

The announcement is unlikely related to the attack on the U.S. Capitol last week, as Cline Amin ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.